BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL
24427 results:

  • 1. Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid leukemia.
    Lamba JK; Marrero R; Wu H; Cao X; Parcha PK; Karol SE; Inaba H; Kuo DJ; Degar BA; Heym K; Taub JW; Lacayo NJ; Pui CH; Ribeiro RC; Pounds SB; Rubnitz JE
    JAMA Netw Open; 2024 May; 7(5):e2411726. PubMed ID: 38753328
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association of serum protein electrophoresis with clinicopathological characteristics and its prognostic relevance in chronic lymphocytic leukaemia patients.
    Hameed A; Sajid N; Javaid RB; Ali N
    J Pak Med Assoc; 2024 Apr; 74(4):711-718. PubMed ID: 38751267
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs.
    Heim D; Baldomero H; Medinger M; Masouridi-Levrat S; Schanz U; Nair G; Güngör T; Halter J; Passweg JR; Chalandon Y;
    Swiss Med Wkly; 2024 May; 154():3754. PubMed ID: 38749067
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical Characteristics and Diagnosis of Ph-Positive Mixed Phenotype Acute leukemia.
    Zhang X; Li R; Zhang X; Li J; Li X; Chen J; Li H
    Clin Lab; 2024 May; 70(5):. PubMed ID: 38747916
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
    Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
    Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeted degradation of oncogenic bcr-abl by silencing the gene of NEDD8 E3 ligase RAPSYN.
    Sun Y; Wang Y; Liu C; Huang Y; Long Q; Ju C; Zhang C; Chen Y
    J Nanobiotechnology; 2024 May; 22(1):247. PubMed ID: 38741123
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Therapeutic Choices in Patients with Ph-Positive Chronic Myelogenous leukemia In Mexico in the Era of Tyrosine Kinase Inhibitors: Stem Cell Transplantation or Tyrosine Kinase Inhibitors? Fifteen Years Later.
    Max RN; Daniela SB; Moisés M GP; Edgar J HF; Merittzel A MR; María de L PM; Juan C OG; Guillermo J RD; Guillermo J RA
    Rev Invest Clin; 2024; 76(2):91-96. PubMed ID: 38740380
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Role of Diet in the Cardiovascular Health of Childhood Cancer Survivors-A Systematic Review.
    Li R; Barker AR; Vlachopoulos D; Paris D; Schindera C; Belle FN; Revuelta Iniesta R
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732563
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia.
    Bono R; Sapienza G; Tringali S; Rotolo C; Patti C; Mulè A; Calafiore V; Santoro A; Castagna L
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727291
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Systematic analysis of mucosal-associated invariant T cells in haematological malignancies.
    Bacova B; Cierny J; Nemcekova L; Smetanova/Brozova J; Novak J
    Scand J Immunol; 2024 Jun; 99(6):e13364. PubMed ID: 38720521
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Frequency and Aberrant CD Marker Profile of Acute Leukaemias.
    Arshad MZ; Hassan MA; Bibi M; Hussain M; Alam M; Riaz MO
    J Coll Physicians Surg Pak; 2024 May; 34(5):539-544. PubMed ID: 38720213
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Chronic myeloid leukemia with e6a2 fusion gene: a case report and literature review].
    Li JJ; Yue LL; Zeng PY; Wu CY; Chen HL
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):299-302. PubMed ID: 38716604
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Clinical significance of IL-18 and IL-18-binding protein in bone marrow of patients with myelodysplastic syndrome].
    Wang T; Ran NY; Chen QL; Liu DL; Zang MT; Li NB; He X; Guan J; Fu R; Shao ZH
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):284-289. PubMed ID: 38716601
    [No Abstract]    [Full Text] [Related]  

  • 14. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
    Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
    [No Abstract]    [Full Text] [Related]  

  • 15. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
    Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
    [No Abstract]    [Full Text] [Related]  

  • 16. Phosphatidylserine and Tyro3-Axl-Mertk Receptor Tyrosine Kinase level detection in plasma and on plasma-derived extracellular vesicle surface in chronic lymphocytic leukemia.
    Bay M; Seval GC; Coskun O; Gurman G; Erdas NO
    Cell Biochem Funct; 2024 Jun; 42(4):e4035. PubMed ID: 38715180
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Combination of an aurora kinase inhibitor and the abl tyrosine kinase inhibitor asciminib against abl inhibitor-resistant CML cells.
    Okabe S; Moriyama M; Gotoh A
    Med Oncol; 2024 May; 41(6):142. PubMed ID: 38714583
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Study on the inhibitory and pro-apoptotic effects of different concentrations of total tanshinone alone and in combination with tyrosine kinase inhibitors on human myeloid leukemia cell lines].
    Zhou XS; Fang JC; Ma XL; Zhang Y; Wang F; Chen X; Wu QS; Cao PX; Liu HX
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(17):1514-1520. PubMed ID: 38706059
    [No Abstract]    [Full Text] [Related]  

  • 19. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Burris HA; Okusaka T; Vogel A; Lee MA; Takahashi H; Breder V; Blanc JF; Li J; Bachini M; Żotkiewicz M; Abraham J; Patel N; Wang J; Ali M; Rokutanda N; Cohen G; Oh DY
    Lancet Oncol; 2024 May; 25(5):626-635. PubMed ID: 38697156
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Novel guanidine derivatives targeting leukemia as selective Src/abl dual inhibitors: Design, synthesis and anti-proliferative activity.
    Moustafa AH; AboulMagd AM; Ali AM; Khodairy A; Marzouk AA; Nafady A; T M Nemr M
    Bioorg Chem; 2024 Jun; 147():107410. PubMed ID: 38688197
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1222.